These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 17255308)

  • 21. A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting.
    Radjenovic A; Ridgway JP; Smith MA
    Phys Med Biol; 2006 May; 51(9):N187-97. PubMed ID: 16625029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.
    Hylton N
    J Clin Oncol; 2006 Jul; 24(20):3293-8. PubMed ID: 16829653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of antiangiogenic and antivascular drug activity by kinetic analysis of DCE-MRI data.
    Ferl GZ; Port RE
    Clin Pharmacol Ther; 2012 Jul; 92(1):118-24. PubMed ID: 22588603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral washout phenomenon in an animal tumour model: comparison of dynamic magnetic resonance imaging using a small molecular contrast medium with histology.
    Drees R; Hünigen H; Wagner S; Schnorr J; Plendl J; Taupitz M
    Vet Comp Oncol; 2008 Sep; 6(3):151-61. PubMed ID: 19178675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
    Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
    Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure.
    Ferretti S; Allegrini PR; O'Reilly T; Schnell C; Stumm M; Wartmann M; Wood J; McSheehy PM
    Clin Cancer Res; 2005 Nov; 11(21):7773-84. PubMed ID: 16278399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
    Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
    Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of tumor histology to dynamic contrast enhanced magnetic resonance imaging-based physiological estimates.
    Aref M; Chaudhari AR; Bailey KL; Aref S; Wiener EC
    Magn Reson Imaging; 2008 Nov; 26(9):1279-93. PubMed ID: 18487033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic contrast-enhanced magnetic resonance imaging in the early evaluation of anti-angiogenic therapy in metastatic renal cell carcinoma.
    Panebianco V; Iacovelli R; Barchetti F; Altavilla A; Forte V; Sciarra A; Cortesi E; Catalano C
    Anticancer Res; 2013 Dec; 33(12):5663-6. PubMed ID: 24324114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study.
    Notohamiprodjo M; Sourbron S; Staehler M; Michaely HJ; Attenberger UI; Schmidt GP; Boehm H; Horng A; Glaser C; Stief C; Reiser MF; Herrmann KA
    J Magn Reson Imaging; 2010 Feb; 31(2):490-501. PubMed ID: 20099364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical studies to predict efficacy of vascular changes induced by combretastatin a-4 disodium phosphate in patients.
    Nielsen T; Murata R; Maxwell RJ; Stødkilde-Jørgensen H; Ostergaard L; Horsman MR
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):859-66. PubMed ID: 18164835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative estimation of dynamic contrast enhanced MRI parameters in rat brain gliomas using a dual surface coil system.
    Pickup S; Chawla S; Poptani H
    Acad Radiol; 2009 Mar; 16(3):341-50. PubMed ID: 19201363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
    Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
    Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of dynamic contrast medium enhanced magnetic resonance imaging in preoperative detection of thyroid carcinoma.
    Tezelman S; Giles Y; Tunca F; Gok K; Poyanli A; Salmaslioglu A; Terzioglu T
    Arch Surg; 2007 Nov; 142(11):1036-41. PubMed ID: 18025330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological animal models in the experimental evaluation of tumour microvasculature with magnetic resonance imaging.
    Faccioli N; Marzola P; Boschi F; Sbarbati A; D'Onofrio M; Pozzi Mucelli R
    Radiol Med; 2007 Apr; 112(3):319-28. PubMed ID: 17440699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging.
    Ellingsen C; Egeland TA; Gulliksrud K; Gaustad JV; Mathiesen B; Rofstad EK
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):838-45. PubMed ID: 19215820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126.
    Evelhoch JL; LoRusso PM; He Z; DelProposto Z; Polin L; Corbett TH; Langmuir P; Wheeler C; Stone A; Leadbetter J; Ryan AJ; Blakey DC; Waterton JC
    Clin Cancer Res; 2004 Jun; 10(11):3650-7. PubMed ID: 15173071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic contrast-enhanced MRI of benign prostatic hyperplasia and prostatic carcinoma: correlation with angiogenesis.
    Ren J; Huan Y; Wang H; Chang YJ; Zhao HT; Ge YL; Liu Y; Yang Y
    Clin Radiol; 2008 Feb; 63(2):153-9. PubMed ID: 18194690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current role and future perspective of MRI for diagnosis and characterization of renal cell carcinoma.
    Schoth F; Persigehl T; Palmowski M
    Panminerva Med; 2010 Dec; 52(4):307-18. PubMed ID: 21183891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic Gd-DTPA enhanced MRI as a surrogate marker of angiogenesis in tissue-engineered bladder constructs: a feasibility study in rabbits.
    Cheng HL; Chen J; Babyn PS; Farhat WA
    J Magn Reson Imaging; 2005 Apr; 21(4):415-23. PubMed ID: 15778952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.